A Disintegrin and Metalloprotease-17 (ADAM-17) Is Expressed In Rheumatoid Arthritis and Mediates Monocyte Migration

被引：0
|
作者：
Isozaki, Takeo [1 ]
Oguro, Nao [1 ]
Seki, Shinya [1 ]
Miura, Yoko [1 ]
Ishii, Sho [1 ]
Tsukamoto, Hiroyuki [1 ]
Tokunaga, Takahiro [1 ]
Umemura, Masayu [1 ]
Furuya, Hidekazu [1 ]
Yanai, Ryo [1 ]
Isojima, Sakiko [1 ]
Wakabayashi, Kuninobu [1 ]
Yajima, Nobuyuki [1 ]
Miwa, Yusuke [1 ]
Kasama, Tsuyoshi [1 ]
机构：
[1] Showa Univ, Sch Med, Shinagawa Ku, Tokyo 142, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
938
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [21] Protective Role Of A Disintegrin And Metalloprotease 17 (adam17) In Elastase-Induced Emphysema In Mice
    Suzuki, S.
    Ishii, M.
    Asakura, T.
    Namkoong, H.
    Okamori, S.
    Yagi, K.
    Kamata, H.
    Kagawa, S.
    Horiuchi, K.
    Hasegawa, N.
    Betsuyaku, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [22] ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease
    Airi Nishimi
    Takeo Isozaki
    Shinichiro Nishimi
    Sho Ishii
    Takahiro Tokunaga
    Hidekazu Furuya
    Kuninobu Wakabayashi
    Tsuyoshi Kasama
    Clinical Rheumatology, 2018, 37 : 1017 - 1024
  • [23] ADAM-17 Is Expressed in the Inflammatory Myopathy, and Is Involved with Interstitial Lung Disease
    Nishimi, Airi
    Isozaki, Takeo
    Nishimi, Shinichiro
    Ishii, Sho
    Tokunaga, Takahiro
    Furuya, Hidekazu
    Wakabayashi, Kuninobu
    Kasama, Tsuyoshi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Conditional deletion of ADAM17 (A disintegrin and metalloprotease 17) in microglia attenuates hypertension and associated inflammation.
    Mohan, Uma Priya
    Dinh, Paula
    Yue, Xinping
    Lazartigues, Eric
    HYPERTENSION, 2024, 81
  • [25] Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
    Chalaris, Athena
    Adam, Nina
    Sina, Christian
    Rosenstiel, Philip
    Lehmann-Koch, Judith
    Schirmacher, Peter
    Hartmann, Dieter
    Cichy, Joanna
    Gavrilova, Olga
    Schreiber, Stefan
    Jostock, Thomas
    Matthews, Vance
    Haesler, Robert
    Becker, Christoph
    Neurath, Markus F.
    Reiss, Karina
    Saftig, Paul
    Scheller, Juergen
    Rose-John, Stefan
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (08): : 1617 - 1624
  • [26] Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease
    Airi Nishimi
    Takeo Isozaki
    Shinichiro Nishimi
    Sho Ishii
    Takahiro Tokunaga
    Hidekazu Furuya
    Kuninobu Wakabayashi
    Tsuyoshi Kasama
    Clinical Rheumatology, 2018, 37 : 1025 - 1026
  • [27] ADAM-17 IS EXPRESSED IN THE INFLAMMATORY MYOPATHY, AND IS INVOLVED WITH INTERSTITIAL LUNG DISEASE (ILD)
    Nishimi, A.
    Isozaki, T.
    Nishimi, S.
    Ishii, S.
    Tokunaga, T.
    Furuya, H.
    Wakabayashi, K.
    Kasama, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 894 - 894
  • [28] Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain
    Lorenzen, Inken
    Trad, Ahmad
    Groetzinger, Joachim
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 415 (02) : 330 - 336
  • [29] Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates
    Stawikowska, Roma
    Cudic, Mare
    Giulianotti, Marc
    Houghten, Richard A.
    Fields, Gregg B.
    Minond, Dmitriy
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (31) : 22871 - 22879
  • [30] Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
    Minond, Dmitriy
    Cudic, Mare
    Bionda, Nina
    Giulianotti, Marc
    Maida, Laura
    Houghten, Richard A.
    Fields, Gregg B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (43) : 36473 - 36487
12345